Health Care Roundup: Medicare Payments for CAR-T; Cancer Screenings in Older Adults; Cancer and At-Home DNA Tests; End of Life Care; More
CAR-T therapies, a cutting-edge type of immunotherapy, are seen by many as the next generation for cancer treatments. Of course, they are expensive and complicated to administer. The Centers for Medicare and Medicaid Services (CMS) recently announced long-awaited policies regarding payment for these treatments. CMS stated, “Medicare will pay for ...
Health Care Roundup: Medicare ‘Step Therapy’ Concerns; Alternative Cancer Treatment Risks; Immunotherapy Scientists Win Nobel Prize; More
HEALTH CARE HIGHLIGHT – NCCS Submits Concerns to HHS Regarding New “Step Therapy” Plan – NCCS joined with other cancer organizations of the Cancer Leadership Council (CLC) in a letter to the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) regarding the ...
NCCS Congratulates Nobel Prize in Medicine Winners for Cancer Immunotherapy Research
Silver Spring, MD – The National Coalition for Cancer Survivorship (NCCS) issued the following statement after the announcement of this year’s winners for the Nobel Prize in Medicine, James P. Allison and Tasuku Honjo, whose research into the human immune system led to immunotherapy cancer drugs. “The National Coalition for ...
Health Care Roundup: Trump Drug Pricing Plan; HHS Cuts ACA Navigator Funding; CAR-T Therapy Coverage Issues; Biosimilar News; and More
Comment Period Closed for Trump Drug Pricing Plan — Comments for the Department of Health and Human Services’ (HHS) drug pricing proposal were due this week. The plan, introduced by the Trump administration, outlined proposals seeking to increase competition, reduce out-of-pocket costs and incentivize better negotiations for lower drug prices ...
What Caught Our Eye: Trump Acts to Undermine ACA; Susan Gubar Reviews ‘Cancer Humor’ Books; Life After Cancer; and More
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. “Trump Administration To End Obamacare Subsidies For The Poor” – The Trump administration said Thursday that it would end the Affordable Care Act’s cost-sharing reduction payments designed ...
What Caught Our Eye: Only 31% View AHCA Favorably, Immunotherapy Hope & Hype, Male Breast Cancer, the Stigma of Lung Cancer
What Caught Our Eye (WCOE), June 2, 2017: “Kaiser Health Tracking Poll Shows Americans View AHCA Unfavorably” — With Congress currently discussing the American Health Care Act (AHCA), a plan that would repeal and replace the 2010 health care law, this month’s Kaiser Health Tracking Poll finds that more Americans ...
WCOE: Medicare’s Draft Decision for Lung Cancer Screenings, Immunotherapy, Breast Cancer Screening
What Caught Our Eye (WCOE) Each week, we take a closer look at the cancer policy articles, studies, and stories that caught our attention. Medicare’s draft decision to pay for lung cancer screenings for older, long-time smokers up to age 74 is likely to continue to spark some controversy. Several items ...
